URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) activated TEG, in vitro hemostatic
system hyperactivity modeling was carried out with the
blood of healthy
of
blood loss. Proagregate effect of Compound I is successfully realized into the
system hemostatic
Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) as a change in the internal
blood coagulation pathway, i.e., the activated partial thromboplastin time
popularity, including the use of
blood
components or
blood cells with a haemostatic purpose. In this re gard